Ryan Karlsson

Dr. Ryan Karlsson

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2026 in JACC: Case Reports
Verified
Journal Article
Open access
RKRyan Karlsson
Ryan Karlsson
JBJohn P. Birrane
John P. Birrane
RORory O'HAnlon
Rory O'HAnlon
AMAndrew O. Maree
Andrew O. Maree
Isolated spontaneous coronary artery dissection (SCAD) of the first septal perforator (S1) is rare. A 48-year-old man presented with chest pain after physical exertion. Coronary angiography demonstrated type 1 SCAD confined to S1. Cardiac magnetic resonance (CMR) confirmed a transmural septal infarction. The patient was managed conservatively with antiplatelet and beta-blocker therapy and experienced an uncomplicated recovery. A limited number of cases of isolated S1 SCAD have been previously reported, predominantly affecting women and all managed conservatively. To our knowledge, this case represents the youngest reported male patient and appears to be the first reported case demonstrating CMR-confirmed transmural septal infarction secondary to type 1 S1 SCAD. Optimal long-term medical therapy remains undefined. SCAD should be considered in patients presenting with chest pain after physical or emotional stress. CMR is a valuable adjunct after angiography in cases of diagnostic uncertainty.

29 April 2025 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
RKRyan Karlsson
Ryan Karlsson
NONiall O’rOurke
Niall O’rOurke
CVChithra Varghese
Chithra Varghese
CDCaroline Daly
Caroline Daly
RKRajesh Kumar
Rajesh Kumar
Background: Sarcoidosis is a systemic inflammatory disease of unknown aetiology characterized by the formation of non-caseating granulomas. Cardiac involvement occurs in up to 30% of cases but only manifests clinically in 5%. In young patients presenting with high-grade atrioventricular block, infiltrative processes such as sarcoidosis should be considered in the differential diagnosis. Case summary: We present the case of a 35-year-old male who presented to hospital with symptomatic complete heart block as the first manifestation of multi-system sarcoidosis with cardiac involvement. Initial blood testing, chest x-ray and transthoracic echocardiography were unremarkable, leaving a broad differential to be considered. Cardiac magnetic resonance imaging revealed late gadolinium enhancement in a highly variable and non-coronary distribution, with simultaneous involvement of subepicardial, subendocardial, and midwall tissue. High-resolution computed tomography of the thorax revealed significant intrathoracic lymphadenopathy. Endobronchial ultrasound-guided lymph node sampling and analysis revealed the presence of non-caseating granulomas, providing histological confirmation of the disease. The patient’s clinical course was complicated by the development of ventricular standstill, thus insertion of an implantable cardioverter-defibrillator was carried out. Immunosuppressive therapy with oral prednisolone was commenced prior to discharge. Discussion: Cardiac sarcoidosis can produce life-threatening complications if left untreated. Our case serves to highlight the need for consideration of sarcoidosis as a cause for cardiac conduction disease in young patients, and the utility of multimodality imaging in its diagnosis. Cardiac magnetic resonance imaging serves as a useful tool when faced with this clinical picture.

6 October 2025 in European Heart Journal - Imaging Methods and Practice
Verified
Journal Article
Open access
RKRyan Karlsson
Ryan Karlsson
MCMichael Cronin
Michael Cronin
CMCian Murray
Cian Murray
RBRoger Byrne
Roger Byrne

24 September 2026 in JACC: Case Reports
Verified
Journal Article
Open access
ARAvinash Radhakrishna
Avinash Radhakrishna
RKRyan Karlsson
Ryan Karlsson
ADAlison Duncan
Alison Duncan
RMRoss T. Murphy
Ross T. Murphy
SOStephen O’COnnor
Stephen O’COnnor
AMAndrew O. Maree
Andrew O. Maree

21 July 2026 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
RKRyan Karlsson
Ryan Karlsson
MCMichael Cronin
Michael Cronin
NSNiall Sheehy
Niall Sheehy
GMGeraldine McMahon
Geraldine McMahon
RMRoss T Murphy
Ross T Murphy
CDCaroline Daly
Caroline Daly
Background:Emergency chest pain presentations represent a substantial burden on healthcare resources. The use of coronary computed tomography angiography (CCTA) has been shown to be safe and associated with reduced costs in stable outpatients referred for invasive coronary angiography (ICA). The history, electrocardiogram, age, risk factors, troponin (HEART) risk assessment score is used to risk-stratify patients with undifferentiated chest pain. We sought to evaluate the cost impact of an accelerated outpatient CCTA-based diagnostic pathway compared with inpatient ICA for the investigation of patients presenting acutely to the emergency department (ED) with symptoms suggestive of coronary artery disease (CAD) at a tertiary referral centre. Methods:We performed a comparative cost analysis based on retrospective observational data including stable adult ED patients who presented in 2023.Results:369 patients underwent outpatient CCTA and 376 were admitted for ICA. The median time to outpatient CCTA was 14 days (interquartile range (IQR) 5–24). Use of the CCTA-based pathway was associated with a 78% reduction in diagnostic pathway costs (€2990 per patient), when compared to admission for ICA, for the investigation of lower-risk individuals, with no increase in 30-day mortality or myocardial infarction. Patients referred for outpatient CCTA had a significantly shorter median length-of-stay compared with those admitted for ICA (6.5 hours (IQR 5.0–9.0) vs. 5 days (IQR 3.0–14.9); p < 0.05). Conclusions:Use of an accelerated outpatient CCTA-based diagnostic pathway for low-risk chest pain patients in the ED was associated with substantial cost savings and reduced hospital utilization without evidence of compromised short-term safety.

20 November 2025 in JACC: Case Reports
Verified
Journal Article
Open access
RKRyan Karlsson
Ryan Karlsson
CHConal Houstoun
Conal Houstoun
MBMicheal Brennan
Micheal Brennan
RMRoss T. Murphy
Ross T. Murphy
EVElisabeth Vandenberghe
Elisabeth Vandenberghe
JNJames Nolan
James Nolan
Clinically apparent cardiac involvement in mycosis fungoides (MF) is a rare phenomenon. A 61-year-old man presented with dyspnea 11 months after allogeneic hematopoietic stem cell transplantation for MF. Echocardiography revealed a large pericardial effusion causing cardiac tamponade. Emergency pericardiocentesis and effusion analysis confirmed disease relapse isolated to the pericardium in the setting of full donor chimerism. Despite reduction in immunosuppression, relapse with cardiac tamponade later recurred. Combined-modality chemotherapy and radiotherapy was administered. Systemic disease relapse occurred 22 months after isolated pericardial relapse. This unique case of life-threatening isolated cardiac involvement in relapsed MF exposes the heart as a potential sanctuary site that may sequester lymphoma cells from systemic therapies and the graft-versus-lymphoma effect. Optimal management of this rare complication is unknown. Pericardial or myocardial infiltration should be considered in patients with MF presenting with cardiac symptoms, conduction disturbance, or shock.